Health Net
Jakafi (ruxolitinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limits Apply
  • Graft Versus Host Disease (GVHD):
    Age Requirement: >= 12
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Bone Marrow Specialist;Hematologist;Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: <= 12 month(s)

    Myelofibrosis:
    Age Requirement: >= 18
    Duration: 1 plan year
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Polycythemia Vera (PV):
    Age Requirement: >= 18
    Duration: 1 plan year
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Hematologist;Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year

  • Anti-Cancer:Maximum $200 copayment per State Law.
  • Step Therapy: Graft Versus Host Disease (GVHD):
    ST Single Generic

  • Prior Authorization: Graft Versus Host Disease (GVHD):
    Documented Diagnosis: Yes
    Age Requirement: >= 12
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Myelofibrosis:
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 1 plan year

    Polycythemia Vera (PV):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 1 plan year
    Reauthorization Required: Yes